Alterity Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Alterity Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Price for Alterity Therapeutics has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Alterity Therapeutics will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CSL Stock Forecast | CSL | Outperform |
12
|
$279.56 | Buy/Sell | $205.51 | -27.33% |
| TLX Stock Forecast | Telix Pharmaceuticals | Buy |
6
|
$14.97 | Buy/Sell | $13.37 | -3.14% |
| NEU Stock Forecast | Neuren Pharmaceuticals | Buy |
11
|
$20.25 | Buy/Sell | $26.43 | 31.26% |
| PNV Stock Forecast | PolyNovo | Outperform |
8
|
$2.12 | Buy/Sell | $1.88 | 0.94% |
| CUV Stock Forecast | Clinuvel Pharmaceuticals | Buy |
16
|
$15.39 | Buy/Sell | $27.41 | 44.57% |
Alterity Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Alterity Therapeutics's Revenue has decreased from $4.34M to $3.92M – a 9.68% drop. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $4.52M – an increase of 15.33%. Over the next seven years, experts anticipate that Revenue growth for Alterity Therapeutics will be 17.92%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMU Stock Forecast | Imugene | Buy |
4
|
$0.08 | Buy/Sell | $0.35 | 425.00% |
| IMM Stock Forecast | Immutep | Buy |
8
|
$0.49 | Buy/Sell | $1.26 | 104.08% |
| OPT Stock Forecast | Opthea | Hold |
10
|
$0.65 | Buy/Sell | $1.15 | 7.69% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$1.18 | Buy/Sell | $0.69 | -6.78% |
| PYC Stock Forecast | PYC Therapeutics | Buy |
8
|
$0.11 | Buy/Sell | $0.30 | 227.27% |
| CGS Stock Forecast | Cogstate | Buy |
11
|
$1.41 | Buy/Sell | $1.85 | 27.66% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BOT Stock Forecast | Botanix Pharmaceuticals | - |
0
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
| DXB Stock Forecast | Dimerix |
0
|
$0.35 | Buy/Sell | $0.00 | 65.71% | |
| ACW Stock Forecast | Actinogen Medical |
5
|
$0.03 | Buy/Sell | $0.15 | -100.00% |
Alterity Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Alterity Therapeutics's EBITDA has grown, increasing from $-13.90M to $-14.60M – an increase of 5.04%. According to the 0 analysts polled, in the next year, Alterity Therapeutics's EBITDA will fall by 1.19%, reaching $-14.43M. Over the next seven years, the pros' prediction is EBITDAof $-14.96M, which would mean a seven-year growth forecast of 2.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIT Stock Forecast | Biotron | - |
0
|
$0.06 | Buy/Sell | $0.00 | -100.00% |
| SPL Stock Forecast | Starpharma Holdings | - |
8
|
$0.12 | Buy/Sell | $0.95 | -100.00% |
| IVX Stock Forecast | Invion | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
Alterity Therapeutics EBIT Forecast for 2023 - 2025 - 2030
Alterity Therapeutics's EBIT has increased by 5.10% In the last three years, going from $-13.93M to $-14.64M. For the next year, 0 analysts project Alterity Therapeutics's EBIT to drop by 1.22%, reaching $-14.46M. For the next seven years, the forecast is for EBIT to grow by 2.38%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PTX Stock Forecast | Prescient Therapeutics |
2
|
$0.05 | Buy/Sell | $0.20 | 180.00% | |
| CYP Stock Forecast | Cynata Therapeutics |
0
|
$0.24 | Buy/Sell | $1.24 | 416.67% | |
| 1AI Stock Forecast | Algorae Pharmaceuticals | - |
-4
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
Alterity Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, EPS for Alterity Therapeutics has grown by 100.00%, going from $-0.01 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Alterity Therapeutics will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMC Stock Forecast | Immuron | - |
0
|
$0.07 | Buy/Sell | $0.00 | -100.00% |
| GTG Stock Forecast | Genetic Technologies | - |
0
|
$0.13 | Buy/Sell | $1.00 | -100.00% |
| OSL Stock Forecast | OncoSil Medical | - |
0
|
$0.01 | Buy/Sell | $0.11 | -100.00% |
Site Navigation
.jpg)